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Introduction
Duchenne muscular dystrophy (DMD) is the most common childhood form of muscular dystrophy. This condition segregates in families with an X-linked pattern of inheritance, though approximately 25% of cases are due to de novo gene mutations (1).Duchenne muscular dystrophy occurs in about 1 out of every 3,600 male infants. Children with DMD typically display skeletal muscle weakness by age 2-6 years(2).Cardiomyopathy is nearly ubiquitous, although the age of onset varies considerably (2-4). Clinical guidelines recommend that evaluations for cardiomyopathy, arrhythmia, and heart failure be performed upon diagnosis, every 2 years thereafter until age 10 years, and then at least yearly thereafter (3). The incidence of cardiomyopathy in DMD increases with age, affecting 30 % of patients by 14 years of age, 50 % of patients by 18 years of age, and up to 90 % of older patients (5). Early detection of muscular dystrophy associated cardiomyopathy isimportant, because institution of cardioprotective medical therapies may slowadverse remodeling and attenuate heart failure symptoms in these patients.So we conducted this study to evaluate cardiac functions in clinically suspected DMD children by clinical evaluation, cardiac biomarkers echocardiography and electrocardiography (ECG).
Patients and methods
Study design: A Prospective case control studywas conducted in theNeuropediatric outpatient clinicand pediatric cardiology clinic at Sohag University Hospital. The Hospital is a tertiary health institution, located in the south zone of Egypt. 28 male children who met criteria for diagnosis of Duchenne muscular dystrophy aged from 3 to 18 years compared to 47 healthy control children and had given informed consent were included in the study. The diagnosis of Duchenne muscular dystrophy was made on the basis of the clinical characteristics together with serum creatine kinase (CK) determinations. We excluded from the study patients who did not give consent. Also we excluded Children with other types of neuromuscular disorders e.g. spinal muscle atrophy, neuropathy, other types of myopathy and myasthenia, Children less than 3 years and more than 18 years and Female children with muscular dystrophy were also excluded . The study protocol was approved by the Research Ethics Board of our institution. heart rate, QRS duration and QRS amplitude. The QT interval was measured from the onset of the QRS complex to the end of the T wave, defined by the return of the terminal Twave to the isoelectric TP baseline. When U waves were present, the end of the T wave was taken as the nadir between the T and U waves. Then QT interval was corrected for heart rate using Bazett's formula (6 -8). Interpretation of every ECG paper was done using specific centile tables for normal values of ECG waves and intervals according to age (9). ECG was examined for any abnormal rhythm (ectopics ,supraventricular or ventricular tachycardia) .
Statistical analysis
Data was analyzed using STATA intercooled version 12.1. Quantitative data was represented as mean, standard deviation, median and range. Data was analyzed using student t-test to compare means of two groups. When the data was not normally distributed Mann-Whitney test was used. Qualitative data was presented as number and percentage and compared using either Chi square test or fisher exact test. Graphs were produced by using Excel or STATA program. P value was considered significant if it was less than 0.05.
Results
Our study involved 28 clinically suspected Duchenne muscular dystrophy children and 47 age matched healthy male children as controls. The mean age of study group was 7.29±3.24 years, range from 3-14 years and the mean age of the control group was 8.06±2. 86 years, with age range from 3 to 14 years (p value 0 .28). 25% of cases had Positive family history of DMD. 35.7% of cases had positive consanguinity. All reported cases had felt the onset of symptoms and muscle weakness between 4-6 years of age. 25 patients had abnormal gait, three were already wheelchair-bound. Heart rate was above normal ranges in 7 cases (25%). In our study we found that all the cases had elevated CPK level (creatine phosphokinase) .The mean CPK level of cases was 2495.79 ± 3457.02 and range from 425 to 114 52 . While CPK level in controls was normal, (p value<0.0001). LDH level was elevated in 19 cases 67.86% of cases. The mean serum LDH level was 1232.07 ± 617.72. All control children have normal LDH level with mean 163.02 ± 109.62, (P value : <0.0001).The mean serum myoglobin level of (DMD) patients was higher relative to that of healthy controls (but still within normal limits) 39.39 ± 7.25 versus 33.68 ±12.38 (ng/ml) respectively with statistically significant difference (P value: 0.01).There was no statistically significant difference between mean serum troponin I level of DMD patients and that of controls 0 .03 ± 0.05 versus 0.01 ±0 .02 (U/L) respectively (p value: 0.37) . Correlating QTc interval to ejection fraction revealed that no significant correlation present (P value= 0.8). All QTc duration values of controls were normal for age. Other parameters of ECG including (pwave amplitude and duration, PR interval QRS duration, axis and voltage and QT interval) were normal for age; no type of arrhythmia could be detected apart from sinus tachycardia figure [1] . SOHAG 
Discussion
Duchenne muscular dystrophy is an inherited X-linked disease associated with absence of dystrophin(10).it is characterized by progressive muscle weakness and inescapable cardiac involvement (11). Children with DMD typically display skeletal muscle weakness by age 2-6 years (2).Cardiomyopathy is nearly ubiquitous; although the age of onset varies considerably ((3, 4) .This suggests that factors other than the absence of dystrophin contribute to cardiomyopathy.Early detection of muscular dystrophy associated cardiomyopathy is important, because institution of cardioprotective medical therapies may slow adverse remodeling and attenuate heart failure symptoms in these patients (12-15).So we conducted our study to detect early subclinical cardiomyopathy as it became now a major cause of morbidity and mortality with increased life expectancy of DMD patients.
The age of our patients range from 3-14 years. 25% of cases had Positive family history of DMD. 35.7% of cases had positive consanguinity. In Gesmar et al., study the age ranged from 6 to 14 years and 45% of his cases had a positive family history of DMD (16).creatine kinase, troponin I , myoglobin, , and lactate dehydrogenase are serum markers of muscle injury (17-19). All our cases had high CPK level, as it is a mainstay in diagnosis of DMD , However results of myoglobin were relatively near to the results of Hathout et al. (20) .cardiomyopathy that develops in DMD is characterized by normal or thinned left ventricular (LV) wall thickness and progressive decline in ejection fraction or fractional shortening. Variable degrees of LV dilation occur. Abnormal LV relaxation has also been identified as an early manifestation in DMD (21). 
Walaa Ibrahim
Our echocardiographic findings agrees with Jefferies et al., who documented that Cardiac disease in DMD population usually consists of dilated cardiomyopathy, which causes progressive decline in the ejection fraction and fractional shortening, and generally evolves to heart failure, even with concomitant arrhythmia (13). 34% of DMD cases in the study of Philip et al., developed cardiomyopathy with follow up (22).,and 30% of DMD cases in the study of Tamara et al developed cardiomyopathy (23). Spurney et al., documented that The age of onset varies considerably, but abnormalities in systolic function are present in more than 80 % of boys older than 18 years of age (24).Our electrocardiographic findings agree with that of Tamara et al., who hypothesized that an elevated heart rate would herald cardiomyopathy onset (23) . In our study QTc prolongation was present regardless presence or absence of echocardiographic findings of cardiomyopathy, this agrees with findings of Philip et al.,who postulated that in their study, ECG changes are similar in patients with DMD regardless of presence of dilated cardiomyopathy (24). Martin et al., documented that a significant number of patients (24% to 32%) with dilated or hypertrophic cardiomyopathy may have a long QTc interval on the surface ECG, and ventricular hypertrophy/dilation may be additional rare causes of acquired prolongation of the QT interval.A lengthening of the QT interval predisposes to torsade de pointes ventricular tachycardia, which can degenerate into ventricular fibrillation (25).
